Cargando…

Inhibition of LpxC Increases the Activity of Iron Chelators and Gallium Nitrate in Multidrug-Resistant Acinetobacter baumannii

Infections caused by multidrug-resistant Acinetobacter baumannii would benefit from the development of novel treatment approaches. Compounds that interfere with bacterial iron metabolism, such as iron chelators and gallium nitrate, have previously been shown to have antimicrobial activity against A....

Descripción completa

Detalles Bibliográficos
Autores principales:	Vinuesa, Víctor, Cruces, Raquel, Nonnoi, Francesca, McConnell, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160660/ https://www.ncbi.nlm.nih.gov/pubmed/34065605 http://dx.doi.org/10.3390/antibiotics10050609

Ejemplares similares

Inhibition of LpxC Protects Mice from Resistant Acinetobacter baumannii by Modulating Inflammation and Enhancing Phagocytosis
por: Lin, Lin, et al.
Publicado: (2012)

The nucleotide-binding site of Aquifex aeolicus LpxC
por: Buetow, Lori, et al.
Publicado: (2006)

Interplay of Klebsiella pneumoniae fabZ and lpxC Mutations Leads to LpxC Inhibitor-Dependent Growth Resulting from Loss of Membrane Homeostasis
por: Mostafavi, Mina, et al.
Publicado: (2018)

Recent Advances in Iron Chelation and Gallium-Based Therapies for Antibiotic Resistant Bacterial Infections
por: Vinuesa, Víctor, et al.
Publicado: (2021)

Regulated Expression of lpxC Allows for Reduction of Endotoxicity in Bordetella pertussis
por: Pérez-Ortega, Jesús, et al.
Publicado: (2022)

Machine learning approaches to study the structure-activity relationships of LpxC inhibitors
por: Yu, Tianshi, et al.
Publicado: (2023)

Chlamydia spp. development is differentially altered by treatment with the LpxC inhibitor LPC-011
por: Cram, Erik D., et al.
Publicado: (2017)

An Essential Membrane Protein Modulates the Proteolysis of LpxC to Control Lipopolysaccharide Synthesis in Escherichia coli
por: Fivenson, Elayne M., et al.
Publicado: (2020)

A New Factor LapD Is Required for the Regulation of LpxC Amounts and Lipopolysaccharide Trafficking
por: Wieczorek, Alicja, et al.
Publicado: (2022)

3D-QSAR, Molecular Docking and Molecular Dynamics Simulation of Pseudomonas aeruginosa LpxC Inhibitors
por: Zuo, Ke, et al.
Publicado: (2017)

Intricate Crosstalk Between Lipopolysaccharide, Phospholipid and Fatty Acid Metabolism in Escherichia coli Modulates Proteolysis of LpxC
por: Thomanek, Nikolas, et al.
Publicado: (2019)

Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC
por: Lemaître, Nadine, et al.
Publicado: (2017)

Application of LpxC enzyme inhibitor to inhibit some fast-growing bacteria in human gut bacterial culturomics
por: Hou, Fengyi, et al.
Publicado: (2019)

LpxC Inhibitors as New Antibacterial Agents and Tools for Studying Regulation of Lipid A Biosynthesis in Gram-Negative Pathogens
por: Tomaras, Andrew P., et al.
Publicado: (2014)

Activity of Gallium Meso- and Protoporphyrin IX against Biofilms of Multidrug-Resistant Acinetobacter baumannii Isolates
por: Chang, David, et al.
Publicado: (2016)

Suppressors of lapC Mutation Identify New Regulators of LpxC, Which Mediates the First Committed Step in Lipopolysaccharide Biosynthesis
por: Maniyeri, Akshay, et al.
Publicado: (2023)

Application of mouse model for evaluation of recombinant LpxC and GmhA as novel antigenic vaccine candidates of Glaesserella parasuis serotype 13
por: JIA, Yong C., et al.
Publicado: (2021)

TP0586532, a non-hydroxamate LpxC inhibitor, reduces LPS release and IL-6 production both in vitro and in vivo
por: Fujita, Kiyoko, et al.
Publicado: (2022)

Multidrug-resistant Acinetobacter baumannii clones persist on hospital inanimate surfaces
por: Rocha, Igor Vasconcelos, et al.
Publicado: (2018)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

lpxC and yafS are the Most Suitable Internal Controls to Normalize Real Time RT-qPCR Expression in the Phytopathogenic Bacteria Dickeya dadantii
por: Hommais, Florence, et al.
Publicado: (2011)

TP0586532, a Novel Non-Hydroxamate LpxC Inhibitor: Potentiating Effect on In Vitro Activity of Meropenem against Carbapenem-Resistant Enterobacteriaceae
por: Yoshida, Ippei, et al.
Publicado: (2022)

Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606
por: Richie, Daryl L., et al.
Publicado: (2016)

Identification and prioritization of potential therapeutic molecules against LpxA from Acinetobacter baumannii – A computational study
por: Khan, Rameez Jabeer, et al.
Publicado: (2023)

Retained colistin susceptibility in clinical Acinetobacter baumannii isolates with multiple mutations in pmrCAB and lpxACD operons
por: Zafer, Mai M., et al.
Publicado: (2023)

Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection
por: LaVergne, Stephanie, et al.
Publicado: (2018)

Antimicrobial Susceptibility Patterns of an Emerging Multidrug Resistant Nosocomial Pathogen: Acinetobacter baumannii
por: Tewari, Rachna, et al.
Publicado: (2018)

Effect of Subinhibitory Concentrations of Antibiotics and Disinfectants on ISAba-Mediated Inactivation of Lipooligosaccharide Biosynthesis Genes in Acinetobacter baumannii
por: Olmeda-López, Héctor, et al.
Publicado: (2021)

Regulation of the First Committed Step in Lipopolysaccharide Biosynthesis Catalyzed by LpxC Requires the Essential Protein LapC (YejM) and HslVU Protease
por: Biernacka, Daria, et al.
Publicado: (2020)

LpxK Is Essential for Growth of Acinetobacter baumannii ATCC 19606: Relationship to Toxic Accumulation of Lipid A Pathway Intermediates
por: Wei, Jun-Rong, et al.
Publicado: (2017)

Multidrug-resistant Acinetobacter baumannii, Russia
por: Naas, Thierry, et al.
Publicado: (2007)

Multidrug-Resistant Acinetobacter baumannii in Jordan
por: Al-Tamimi, Mohammad, et al.
Publicado: (2022)

Acquisition of Colistin Resistance Links Cell Membrane Thickness Alteration with a Point Mutation in the lpxD Gene in Acinetobacter baumannii
por: Saleh, Neveen M., et al.
Publicado: (2020)

Pan-Resistome Insights into the Multidrug Resistance of Acinetobacter baumannii
por: Rodrigues, Diego Lucas Neres, et al.
Publicado: (2021)

Role of Fibronectin in the Adhesion of Acinetobacter baumannii to Host Cells
por: Smani, Younes, et al.
Publicado: (2012)

Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
por: Fournier, Pierre-Edouard, et al.
Publicado: (2006)

Optimal Therapy for Multidrug-Resistant Acinetobacter baumannii
por: Cunha, Burke A.
Publicado: (2010)

Multidrug-Resistant Acinetobacter baumannii Clone, France
por: Bonnin, Rémy A., et al.
Publicado: (2013)

Susceptibility Patterns of Multidrug-Resistant Acinetobacter baumannii
por: Konca, Capan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tof1nt4cmnirmgsb8n66fp0smv